These results provide new information that proinsulin is a reliable biomarker for predicting incident T2D beyond other established clinical markers including age, sex, BMI, family history of diabetes, blood pressure, triglycerides, HDL cholesterol, and FPG [19]. This evidence concerns the gene INS and type 2 diabetes mellitus.